GlassScriptPhysician profile
Perri Winston
NPI 1700203445
$6,320.98
in general payments reported to CMS, 2019-2025
34 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,278 · 2022: $1,774 · 2023: $1,874 · 2024: $1,289 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,199 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,198.93 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $992.36 | 2021-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $714.38 | 2021-2025 | |
| Abbott Laboratories | $701.36 | 2021-2024 | Cardiomems |
| Janssen Pharmaceuticals, INC | $463.30 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $451.96 | 2021-2025 | Vigilant X4 Crt-D, Bodyguardian, Watchman Flx |
| Esperion Therapeutics, INC. | $381.66 | 2021-2023 | Nexletol |
| Merck Sharp & Dohme LLC | $348.75 | 2021-2024 | Verquvo |
| Amgen INC. | $219.89 | 2021-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.17 | 2021-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.65 | 2021-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $183.60 | 2024-2025 | Opsumit, Uptravi |
| Endologix LLC | $166.99 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $137.20 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $131.21 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $128.01 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $104.40 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $100.38 | 2022-2023 | Arcalyst |
| Amarin Pharma, INC. | $89.87 | 2021-2022 | |
| Pfizer INC. | $85.53 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $72.13 | 2023 | Camzyos, Eliquis |
| Tactile Systems Technology INC | $69.85 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Chiesi USA, INC. | $57.46 | 2021-2022 | |
| Medtronic, INC. | $46.85 | 2022-2023 | Intellis Adaptivestim, Micra |
| Cardiva Medical, INC. | $45.34 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Irhythm Technologies, INC. | $39.54 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $31.28 | 2023 | Inpefa |
| Abiomed | $30.51 | 2024 | Impella |
| Janssen Scientific Affairs, LLC | $22.73 | 2024 | Xarelto |
| Novo Nordisk INC | $21.78 | 2024 | Ozempic |
| Scpharmaceuticals INC. | $21.24 | 2024 | |
| Surmodics, INC. | $19.42 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Thrombectomy |
| Cvrx, INC. | $16.24 | 2025 | Barostim Neo System |
| Cashflow Solutions, LLC | $14.99 | 2022 | |
| G Medical Diagnostic Services, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perri Winston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.